Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Study shows strong association between treatment with TNF-blocking antibodies and development of serious infections

A new meta-analysis of many previous studies of TNF- (tumor necrosis factor) blocking antibodies for treatment of rheumatoid arthritis has confirmed a previously discovered increased risk for serious infection and has found that cancer also is a potential risk associated with the drugs.

17 May 2006

Levofloxacin-based triple therapy against persistent ulcer-inducing bacteria successful

For those who suffer from stomach ulcers, the daily routine of breakfast, lunch and dinner can be painful.

10 May 2006

Trial of hepatitis C vaccine underway

Human clinical trials involving investigational vaccines to prevent Hepatitis C are rare. In the fall of 2003 there was a first-ever study at Saint Louis University Center for Vaccine Development, and an earlier small study at Johns Hopkins School of Medicine.

8 May 2006

Saint Louis University hunt for a Hepatitis C vaccine

3 May 2006

New treatment against persistent ulcer-inducing bacteria successful

For those who suffer from stomach ulcers, the daily routine of breakfast, lunch and dinner can be painful. A common cause of these ulcers, as well as other gastric malignancies, is a bacterium called Helicobacter pylori .

1 May 2006

Hypnotherapy relieves chest pain not linked to heart disease

According to a small study in the UK, hypnotherapy was helpful in relieving the angina-like chest pain experienced by some people which is not caused by heart disease.

23 Apr 2006

Researchers find genetic "signature" that accurately identifies colon cancer

Researchers at Jefferson Medical College in Philadelphia have uncovered a genetic "signature" that accurately identifies colon cancer--a key, they hope, to better understand how the cancer develops.

13 Apr 2006

Drug firms in the business of 'diseasemongering'

Australian scientists have accused drug companies of inventing diseases to sell more of their products.

12 Apr 2006

Men's and women's brains behave differently

A key part of the brain involved in processing emotionally-influenced memories acts differently in men and women, even in the absence of stimuli, UC Irvine researchers have found.

11 Apr 2006

Photodynamic therapy may become the first line of treatment for Barrett's esophagus

When you think of heartburn, you probably think of greasy food, not cancer. You may not know that chronic heartburn is linked to esophageal cancer.

7 Apr 2006

Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis

The unchecked activity of a cell signaling pathway crucial in embryonic development and the liver's response to injury leads to liver cancer, researchers from Duke University Medical Center and John Hopkins University School of Medicine have found.

4 Apr 2006

Treatment reduces gastric ulcers in at-risk patients using long-term NSAIDS

Esomeprazole magnesium can reduce the incidence of gastric (stomach) ulcers in patients at risk of developing gastric ulcers and who regularly take either non-selective nonsteroidal anti-inflammatory drugs (NSAIDs) or COX-2-selective NSAIDs

30 Mar 2006

Ocean Vesivirus found in human blood samples

A virus of ocean origin that can cause a range of diseases in several animal species has been found in human blood samples. The virus, or antibodies to it, was found most often in the blood of individuals with liver damage, or hepatitis of unknown cause related to blood exposure.

28 Mar 2006

Remicade (infliximab) gains Australian approval for treatment of early rheumatoid arthritis

Schering-Plough Corporation today announced that the Therapeutic Goods Administration of the Department of Health and Ageing in Australia has revised the indication of Remicade (infliximab) to include the treatment of early rheumatoid arthritis (RA) and approved a new indication for psoriatic arthritis (PsA).

23 Mar 2006

Rapamycin (sirolimus) may be effective in treating kidney disease

A widely available drug may be effective in treating kidney disease, report scientists at the University of California, Santa Barbara. They describe the discovery in the online edition of the Proceedings of the National Academies of Science.

21 Mar 2006

African American women urged to confront colorectal cancer

Despite having the greatest risk of developing and dying from colorectal cancer (CRC) of any gender, race or ethnicity, an astounding 96 percent of African American women do not consider themselves to be at high risk for the disease, according to a new Harris poll.

17 Mar 2006